Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 64,860Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 68BTCP PHARMA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 8486973

Drug Substance Claim :

Drug Product Claim :

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2030-04-27

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 8486973

Drug Substance Claim :

Drug Product Claim :

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2030-04-27

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 8486973

Drug Substance Claim :

Drug Product Claim :

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2030-04-27

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 8486973

Drug Substance Claim :

Drug Product Claim :

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2030-04-27

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 8835460

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2027-01-25

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 8835460

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2027-01-25

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 9642797

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2027-01-25

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 9642797

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2027-01-25

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 9642797

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2027-01-25

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

FENTANYL

US Patent Number : 9289387

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202788

Patent Use Code : U-55

Delist Requested :

Patent Use Description : TREATMENT OF PAIN

Patent Expiration Date : 2027-01-25

blank